Skip to main content

Epidemiological Trends in Colorectal Cancer

  • Chapter
Colorectal Cancer

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Colorectal cancer is the fourth most common cancer worldwide, accounting for approximately 10% of the world total with 782,800 new cases in 1990 (Table 1) (1). In 1990, it accounted for 437,000 deaths (2). It is particularly common in North America, Australia, New Zealand, and parts of Europe, is rare in Asia, and is uncommon in Africa. In developed countries, the lifetime probability of developing colorectal cancer is 4.6% in men and 3.2% in females (2). It affects men and women almost equally, with a similar incidence and number of deaths in the two sexes (3,4). As we enter the new millennium, the incidence and mortality rates for colorectal cancer overall are now declining (5). Rectal cancer incidence, however, as a separate entity, has remained relatively stable over this same time period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin D. Epidemiology of cancer: global patterns and trends. Toxicol. Lett., 102–103 (1998) 227–234.

    Article  Google Scholar 

  2. Parkin D, Pisani P, and Ferlay J. Global cancer statistics. CA: Cancer J. Clin., 49 (1999) 33–64.

    Article  CAS  Google Scholar 

  3. Pisani P, Parkin D, Bray F, etal. Estimates of worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83 (1999) 18–29.

    Article  PubMed  CAS  Google Scholar 

  4. Potter J, Slattery M, Bostick R, etal. Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15 (1993) 499–535.

    PubMed  CAS  Google Scholar 

  5. Ries L, Wingo P, Miller D, etal. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer, 88 (2000) 2398–2424.

    Article  PubMed  CAS  Google Scholar 

  6. Greenlee R, Murray T, Bolden S, etal. Cancer statistics, 2000. CA Cancer J. Clin., 50 (2000) 7–33.

    Article  PubMed  CAS  Google Scholar 

  7. Ries L, Eisner M, Kosary C, etal. SEER Cancer Statistics Review, 1973–1997. National Cancer Institute, Bethesda, MD, 2000.

    Google Scholar 

  8. Parkin D. Cancer Incidence in Five Continents. IARC Scientific Publications, Lyon, 1997.

    Google Scholar 

  9. Parkin D, Pisani P, and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 80 (1999) 827–841.

    Article  PubMed  CAS  Google Scholar 

  10. Correa P and Haenszel W. The epidemiology of large bowel cancer. Adv. Cancer Res., 26 (1978) 1–141.

    Article  PubMed  CAS  Google Scholar 

  11. Sandler R. Epidemiology and risk factors for colorectal cancer. Gastroenterol. Clin. North Am., 25 (1996) 717–735.

    Article  PubMed  CAS  Google Scholar 

  12. Crespi M and Caperle M. Trends in epidemiology of colorectal cancer. J. Surg. Oncol., 2 (Suppl.) (1991) 1–3.

    Article  CAS  Google Scholar 

  13. Wilmink A. Overview of the epidemiology of colorectal cancer. Dis. Colon Rectum, 40 (1997) 483–493.

    Article  PubMed  CAS  Google Scholar 

  14. Sturmer T, Glynn R, Lee I-M, etal. Lifetime cigarette smoking and colorectal cancer incidence in the Physicians’ Health Study I. J. Natl. Cancer Inst., 92 (2000) 1178–1181.

    Article  PubMed  CAS  Google Scholar 

  15. Colditz G, Cannuscio C, and Frazier A. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control, 8 (1997) 649–667.

    Article  PubMed  CAS  Google Scholar 

  16. Thun M, Namboodiri M, and Heath C. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325 (1991) 1593–1596.

    Article  PubMed  CAS  Google Scholar 

  17. Giardello F, Hamilton S, Krush A, etal. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328 (1993) 1313–1316.

    Article  Google Scholar 

  18. Steinbach G, Lynch P, Phillips K, etal. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342 (2000) 1946–1952.

    Article  PubMed  CAS  Google Scholar 

  19. SEER. SEER Cancer Statistics Review, 1972–1996. National Cancer Institute, Bethesda, MD, 1997.

    Google Scholar 

  20. Kune S, Kune G, and Watson L. The Melbourne Colorectal Cancer Study: incidence findings by age, sex, site, migrants and religion. Int. J. Epidemiol., 15 (1986) 483–493.

    Article  PubMed  CAS  Google Scholar 

  21. Walker A and Segal I. Puzzles in the epidemiology of colon cancer. J. Clin. Gastroenterol., 11 (1989) 10–11.

    Article  PubMed  CAS  Google Scholar 

  22. Levin K and Dozois R. Epidemiology of large bowel cancer. World J. Surg., 15 (1991) 562–567.

    Article  PubMed  CAS  Google Scholar 

  23. Shimizu M, Mack T, Ross R, etal. Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County../. Natl. Cancer Inst., 78 (1987) 223–228.

    CAS  Google Scholar 

  24. Flood D, Weiss N, Cook L, etal. Colorectal cancer incidence in Asian migrants in the United States and their descendants. Cancer Causes Control, 11 (2000) 403–411.

    Article  PubMed  CAS  Google Scholar 

  25. Whittemore A, Wu-Williams A, Lee M, etal. Diet, physical activity, and colorectal cancer among Chinese in North America and China. J. Natl. Cancer Inst., 82 (1990) 915–926.

    Article  PubMed  CAS  Google Scholar 

  26. Hill M, Morson B, and Bussey H. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet, 1 (1978) 245–247.

    Article  PubMed  CAS  Google Scholar 

  27. Vogelstein B, Fearon E, Hamilton S, etal. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319 (1988) 525–532.

    Article  PubMed  CAS  Google Scholar 

  28. Fearon E, Cho K, Nigro J, etal. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science, 247 (1990) 49–56.

    Article  PubMed  CAS  Google Scholar 

  29. Fearon E and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell, 61 (1990) 759–767.

    Article  PubMed  CAS  Google Scholar 

  30. Ohue M, Tornita N, Monden T, etal. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res., 54 (1994) 4798–4804.

    PubMed  CAS  Google Scholar 

  31. Bodmer W, Bailey C, Bodmer J, etal. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature, 328 (1987) 614–616.

    Article  PubMed  CAS  Google Scholar 

  32. Kim E and Lance R. Colorectal polyps and their relationship to cancer. Gastroenterol. Clin. North Am., 26 (1997) 1–17.

    Article  PubMed  CAS  Google Scholar 

  33. Powell S, Zilz N, Beazer-Barclay Y, etal. APC mutations occur early during colorectal tumorigenesis. Nature, 359 (1992) 235–237.

    Article  PubMed  CAS  Google Scholar 

  34. Boland C, Sato J, Appelman H, etal. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Med., 1 (1995) 902–909.

    Article  PubMed  CAS  Google Scholar 

  35. Miyaki M, Konishi M, Kikuchi-Yanoshita R, etal. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res., 54 (1994) 3011–3020.

    PubMed  CAS  Google Scholar 

  36. Baeg G, Matsumine A, Kuroda T, etal. The tumor suppressor gene product APC blocks cell cycle progression from GO/G1 to S phase. EMBO J., 14 (1995) 5618–5625.

    PubMed  CAS  Google Scholar 

  37. Browne S, Williams A, Hague A, etal. Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int. J. Cancer, 59 (1994) 56–64.

    Article  PubMed  CAS  Google Scholar 

  38. Burchill S. The tumour suppressor APC product is associated with cell adhesion. Bioassays, 16 (1994) 225–227.

    Article  CAS  Google Scholar 

  39. Smith A, Stern H, Penner M, etal. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54 (1994) 5527–5530.

    PubMed  CAS  Google Scholar 

  40. Minamoto T, Yamashita N, Ochiai A, etal. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer, 75 (1995) 1520–1526.

    Article  PubMed  CAS  Google Scholar 

  41. Pretlow T. Aberrant crypt foci and K-ras mutations: earliest recognised players or innocent bystanders in colon carcinogenesis? Gastroenterology, 108 (1995) 600–603.

    Article  PubMed  CAS  Google Scholar 

  42. Jen J, Kim H, Piantadosi S, etal. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 331 (1994) 213–221.

    Article  PubMed  CAS  Google Scholar 

  43. Cunningham J, Lust J, Schaid D, etal. Expression of p53 and allelic loss in colorectal carcinoma. Cancer Res, 52 (1992) 1974–1980.

    PubMed  CAS  Google Scholar 

  44. Lane D. Cancer, p53, guardian of the genome. Nature, 358 (1992) 15–16.

    Article  PubMed  CAS  Google Scholar 

  45. Donehower L and Bradley A. The tumor suppressor p53. Biochem. Biophys. Acta, 1155 (1993) 181–205.

    PubMed  CAS  Google Scholar 

  46. Tomlinson I, Ilyas M, and Novelli M. Molecular genetics of colon cancer. Cancer Metastasis Rev., 16 (1997) 62–79.

    Article  Google Scholar 

  47. Liu B, Nicolaides N, Markowitz S, etal. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat. Genet., 9 (1995) 48–55.

    Article  PubMed  CAS  Google Scholar 

  48. Liu B, Parsons R, Papadopoulos N, etal. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med., 2 (1996) 148–156.

    Article  Google Scholar 

  49. Young J, Leggett B, Gustafson C, etal. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat., 2 (1993) 351–354.

    Article  PubMed  CAS  Google Scholar 

  50. Jacoby R, Marshall D, Kailas S, etal. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology, 109 (1995) 73–82.

    Article  PubMed  CAS  Google Scholar 

  51. Herman J, Merlo A, Mao L, etal. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55 (1995) 4525–4530.

    PubMed  CAS  Google Scholar 

  52. Devesa S and Chow W-H. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer, 71 (1993) 3819–3826.

    Article  PubMed  CAS  Google Scholar 

  53. Adami H. Aspects of descriptive epidemiology and survival in colorectal cancer. Scand. J. Gastroenterol., 23 (1988) 6–20.

    Article  Google Scholar 

  54. Nelson R, Persky V, and Turyk M. Time trends in distal colorectal cancer subsite location related to age and how it affects choice of screening modality. J. Surg. Oncol., 69 (1998) 235–238.

    Article  PubMed  CAS  Google Scholar 

  55. Cooper G, Yuan Z, Landefeld C, etal. A national population-based study of incidence of colorectal cancer and age. Implications of screening in older Americans. Cancer, 75 (1995) 775–781.

    Article  PubMed  CAS  Google Scholar 

  56. Ghahremani G and Dowlatshahi K. Colorectal carcinomas: diagnostic implications of their changing frequency and anatomic distribution. World J. Surg., 13 (1989) 321–325.

    Article  PubMed  CAS  Google Scholar 

  57. Stewart R, Stewart A, Turnbull P, etal. Sex differences in subsite incidence of large-bowel cancer. Dis. Colon Rectum, 26 (1983) 658–660.

    Article  PubMed  CAS  Google Scholar 

  58. Graham S, Marshall J, Haughey B, etal. Dietary epidemiology of cancer of the colon in western New York. Am. J. Epidemiol., 128 (1988) 409–503.

    Google Scholar 

  59. West D, Slattery M, Robison L, etal. Dietary intake and colon cancer. Sex and anatomic site-specific associations. Am. J. Epidemiol., 130 (1989) 883–894.

    PubMed  CAS  Google Scholar 

  60. McMichael A and Potter J. Diet and colon cancer. Integration of the descriptive, analytic and metabolic epidemiology. J. Natl. Cancer Inst., 69 (1985) 223–228.

    CAS  Google Scholar 

  61. Giovannucci E, Colditz G, and Stampfer M. Cholecystectomy and the risk for colorectal cancer: a meta-analysis. Gastroenterology,105 (1993) 130–141.

    Google Scholar 

  62. Talley N. Cholecystectomy and the risk of colorectal cancer. Ann. Intern. Med., 120 (1994) 24–25.

    Google Scholar 

  63. Neugut AI, Murray T, Garbowski GC, etal. Cholecystectomy as a risk factor for colorectal adenomatous polyps and cancer. Cancer,68 (1991) 1644–1647.

    Google Scholar 

  64. Cancers, nutrition and food. Colon, rectum. In Food, Nutrition and the Prevention of Cancer: A Global Perspective. Potter J (ed.), American Institute for Cancer Research, Washington, DC, 1997, pp. 216–251.

    Google Scholar 

  65. Fuchs C, Giovannucci E, Colditz G, etal. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med., 340 (1999) 169–176.

    Article  PubMed  CAS  Google Scholar 

  66. Fuchs C, Giovannucci E, Colditz G, etal. A prospective study of family history and the risk of colorectal cancer. N. Engl. J. Med., 331 (1994) 1669–1674.

    Article  PubMed  CAS  Google Scholar 

  67. Petersen G. Genetic epidemiology of colorectal cancer. Eur. J. Cancer, 31A (1995) 1047–1050.

    Article  Google Scholar 

  68. Rozen P, Fireman Z, Figer A, etal. Family history of colorectal cancer as a marker of potential malignancy within a screening program. Cancer, 60 (1987) 248–254.

    Article  PubMed  CAS  Google Scholar 

  69. Ahsan H, Neugut AI, Garbowski GC, etal Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann. Intern. Med., 128 (1998) 900–905.

    Article  PubMed  CAS  Google Scholar 

  70. Lal G and Gallinger S. Familial adenomatous polyposis. Semin. Surg. Oncol., 18 (2000) 314–323.

    Article  PubMed  CAS  Google Scholar 

  71. Mecklin J. Frequency of hereditary colorectal carcinoma. Gastroenterology, 93 (1987) 1021–1025.

    PubMed  CAS  Google Scholar 

  72. Bulfill J. Evidence for distinct genetic categories based on proximal distal tumor location. Ann. Intern. Med., 113 (1990) 779–788.

    Article  Google Scholar 

  73. Jiricny J and Nystrom-Lahti M. Mismatch repair defects in cancer. Curr. Opin. Genet. Dev., 10 (2000) 157–161.

    Article  PubMed  CAS  Google Scholar 

  74. Lynch H, Smyrk T, and Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet. Cytogenet., 93 (1997) 84–99.

    Article  PubMed  CAS  Google Scholar 

  75. Langholz E, Munkholm P, and Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology,103 (1992)1111 1451.

    Google Scholar 

  76. Gilat T, Fireman Z, Grossman A, etal. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology, 94 (1988) 870–877.

    PubMed  CAS  Google Scholar 

  77. Ekbom A, Helmick C, Zack M, etal. Ulcerative colitis and colorectal cancer: a population-based study. N. Engl. J. Med., 323 (1990) 1228–1233.

    Article  PubMed  CAS  Google Scholar 

  78. Bernstein C, Shanahan F, and Weinstein W. Are we telling the truth about surveillance colonoscopy in ulcerative colitis? Lancet, 343 (1994) 71–74.

    Article  PubMed  CAS  Google Scholar 

  79. Hordijk M and Shivonanda S. Risk of cancer in inflammatory bowel disease: why are the results in the reviewed literature so varied? Scand. J. Gastroenterol., 170 (1989) 70–74, 81–82.

    Google Scholar 

  80. Isbell G and Levin B. Ulcerative colitis and colon cancer. Gastroenterol. Clin. North Am., 17 (1988) 733–791.

    Google Scholar 

  81. Ohman U. Colorectal carcinoma in patients with ulcerative colitis. Am. J. Surg., 144 (1982) 344–349.

    Article  PubMed  CAS  Google Scholar 

  82. Choi P, Nugent F, and Rossi R. Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis. Gastroenterology, 103 (1992) 1707–1709.

    PubMed  CAS  Google Scholar 

  83. D’Haens G, Lashner B, and Hanauer S. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am. J. Gastroenterol., 88 (1993) 1174–1178.

    PubMed  Google Scholar 

  84. Katzka I, Brody R, Morris E, etal. Assessment of colorectal risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology, 85 (1983) 22–29.

    PubMed  CAS  Google Scholar 

  85. Connell W, Kamm M, Dickson M, etal. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet, 343 (1994) 1249–1252.

    Article  PubMed  CAS  Google Scholar 

  86. Lashner B, Provencher K, Seidner D, etal. The effect of folic acid supplementation on the risk of cancer or dysplasia in ulcerative colitis. Gastroenterology, 107 (1997) 117–120.

    Google Scholar 

  87. Tarmin L, Yin J, Harpaz N, etal. Adenomatous polyposis gene mutations in ulcerative colitis-associated dysplasia and cancers versus sporadic colon neoplasms. Cancer Res., 55 (1995) 2035–2038.

    PubMed  CAS  Google Scholar 

  88. Brentnall T, Crispin D, Rabinovitch P, etal. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology, 107 (1994) 369–378.

    PubMed  CAS  Google Scholar 

  89. Snapper S, Syngal S, and Friedman L. Ulcerative colitis and colon cancer: more controversy than clarity. Dig. Dis., 16 (1998) 81–87.

    Article  PubMed  CAS  Google Scholar 

  90. Persson P, Karlen P, Bernell O, etal. Crohn’s disease and cancer: a population-based cohort study. Gastroenterology, 107 (1994) 1675–1679.

    PubMed  CAS  Google Scholar 

  91. Hamilton S. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology, 89 (1985) 398–407.

    PubMed  CAS  Google Scholar 

  92. Ekbom A, Helmick C, Zack M, etal. Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet, 336 (1990) 357–359.

    Article  PubMed  CAS  Google Scholar 

  93. Pollard M and Luckert P. Treatment of chemically-induced intestinal cancers with indomethacin. Proc. Soc. Exp. Biol. Med.,167 (1981) 161–164.

    Google Scholar 

  94. Reddy B, Maruyama H, and Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47 (1987) 5340–5346.

    PubMed  CAS  Google Scholar 

  95. Rubio C, Wallin B, Ware J, etal. Effect of indomethacin in autotransplanted colonic tumors. Dis. Colon Rectum, 32 (1989) 488–489.

    Article  PubMed  CAS  Google Scholar 

  96. Skinner S, Penney A, and O’Brian P. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch. Surg., 126 (1991) 1094–1096.

    Article  PubMed  CAS  Google Scholar 

  97. Craven P and Derubertis E Effects of aspirin on 1,-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis, 13 (1992) 541–546.

    Article  PubMed  CAS  Google Scholar 

  98. Barnes C, Cameron I, Hardman W, etal. Non-steroidal anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br. J. Cancer, 77 (1998) 573–580.

    Article  PubMed  CAS  Google Scholar 

  99. Gupta R and DuBois R. Aspirin, NSAIDs, and colon cancer prevention: mechanisms [editorial]. Gastroenterology, 114 (1998) 1095–1098.

    Google Scholar 

  100. Labayle D, Fischer D, Vielh P, etal. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101 (1991) 635–639.

    PubMed  CAS  Google Scholar 

  101. Kune G, Kune S, and Watson L. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48 (1988) 4399–4404.

    PubMed  CAS  Google Scholar 

  102. Rosenberg L, Palmer J, Zauber A, etal. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst., 83 (1991) 355–358.

    Article  PubMed  CAS  Google Scholar 

  103. Thun M, Namboodiri M, Calle E, etal. Aspirin use and risk of fatal cancer. Cancer Res., 53 (1993) 1322–1327.

    PubMed  CAS  Google Scholar 

  104. Logan R, Little J, Hawkin P, etal. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J., 307 (1993) 285–289.

    Article  CAS  Google Scholar 

  105. Peleg I, Maibach H, Brown S, etal. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154 (1994) 394–399.

    Article  PubMed  CAS  Google Scholar 

  106. Suh O, Mettlin C, and Petrelli N. Aspirin use, cancer, and polyps of the large bowel. Cancer, 72 (1993) 1171–1177.

    Article  PubMed  CAS  Google Scholar 

  107. Greenberg E, Baron J, Freeman D, etal. Reduced risk of large-bowel adenomas among aspirin users. J. Natl. Cancer Inst., 85 (1993) 912–916.

    Article  PubMed  CAS  Google Scholar 

  108. Schreinemachers D and Everson R. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5 (1994) 138–146.

    Article  PubMed  CAS  Google Scholar 

  109. Gann P, Manson J, Glynn J, etal. Low-dose aspirin and incidence of colorectal cancers in a randomized trial. J. Natl. Cancer Inst., 85 (1993) 1220–1224.

    Article  PubMed  CAS  Google Scholar 

  110. Paganini-Hill A, Chao A, Ross R, etal. Aspirin use and chronic disease: a cohort study of the elderly. Br. Med. J., 229 (1989) 1247–1250.

    Article  Google Scholar 

  111. Lashner B and Epstein S. Industrial risk factors for colorectal cancer. Int. J. Health Serv., 20 (1990) 459–483.

    Article  PubMed  CAS  Google Scholar 

  112. Neugut AI and Wylie P. Occupational cancers of the gastrointestinal tract, Part I: colon, stomach, and esophagus. Occup. Med. State-of-the-Art-Rev., 2 (1987) 109–135.

    CAS  Google Scholar 

  113. Levine D. Does asbestos exposure cause gastrointestinal cancer? Dig. Dis. Sci., 30 (1985) 1189–1198.

    Article  PubMed  CAS  Google Scholar 

  114. Morgan R, Foliart D, and Wong O. Asbestos and gastrointestinal cancer. West. J. Med., 143 (1985) 60–65.

    PubMed  CAS  Google Scholar 

  115. Miller A. Asbestos fiber dust and gastrointestinal malignancies. Review of literature with regard to a cause/effect relationship. J. Chronic Dis., 31 (1978) 23–33.

    Article  Google Scholar 

  116. Ehrlich A, Rohl A, and Holstein E. Asbestos bodies and carcinoma of colon in an insulation worker with asbestos. JAMA, 254 (1985) 2932–2933.

    Article  PubMed  CAS  Google Scholar 

  117. Neugut AI, Murray TI, Garbowski GC, etal. Association of asbestos exposure with colorectal adenomatous polyps and cancer. J. Natl. Cancer Inst., 83 (1991) 1827–1828.

    Article  PubMed  CAS  Google Scholar 

  118. O’Berg M. Epidemiological study of workers exposed to acrylonitrile.. 1. Occup. Med., 22 (1980) 245–252.

    Google Scholar 

  119. Werner J and Carter J. Mortality of United Kingdom acrylonitrile polymerization workers. Br. J. Ind. Med., 38 (1981) 247–253.

    PubMed  CAS  Google Scholar 

  120. Wong O, Brocker W, Davis H, etal. Mortality of workers potentially exposed to organic and inorganic brominated chemicals, DBCP, TRIS, PBB, and DDT. Br. J. Ind. Med., 41 (1984) 15–24.

    PubMed  CAS  Google Scholar 

  121. Ditraglia D, Brown D, Namekata T, etal. Mortality study of workers employed at organochlorine pesticide manufacturing plants. Scand. J. Work Environ. Health, 7 (1981) 140–146.

    PubMed  CAS  Google Scholar 

  122. Greene M, Hoover R, Eck R, etal. Cancer mortality among printing plant workers. Environ. Res., 20 (1979) 66–73.

    Article  PubMed  CAS  Google Scholar 

  123. Lloyd J, Decouffle P, and Salvin L. Unusual mortality experience of printing pressmen. J. Occup. Med., 19 (1977) 543–550.

    PubMed  CAS  Google Scholar 

  124. Swanson G and Belle S. Cancer morbidity among woodworkers in the U.S. automotive industry. J. Occup. Med., 24 (1982) 315–319.

    PubMed  CAS  Google Scholar 

  125. Swanson G, Belle S, and Burrows R. Colon cancer incidence among model makers and patternmakers in the automotive manufacturing industry. J. Occup. Med., 27 (1985) 567–569.

    Article  PubMed  CAS  Google Scholar 

  126. Delzell E and Monson R. Mortality among rubber workers: processing workers. J. Occup. Med., 24 (1982) 539–545.

    PubMed  CAS  Google Scholar 

  127. McMichael A, Spirtas M, and Kupper L. An epidemiologic study of mortality within a cohort of rubber workers: 1964–1972. J. Occup. Med., 16 (1974) 458–464.

    PubMed  CAS  Google Scholar 

  128. Parkes H, Veys C, Waterhouse J, etal. Cancer mortality in the British rubber industry. Br. J. Ind. Med., 39 (1982) 209–220.

    PubMed  CAS  Google Scholar 

  129. Morgan R, Kaplan S, and Gaffey W. A general mortality study of workers in the painting and coating manufacturing industry. J. Occup. Med., 23 (1981) 13–21.

    Article  PubMed  CAS  Google Scholar 

  130. Lee WC, Neugut AI, Garbowski GC, etal. Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps. Ann. Epidemiol., 3 (1993) 239–244.

    Article  PubMed  CAS  Google Scholar 

  131. Hoff G, Vatn M, and Larsen S. Relationship between tobacco smoking and colorectal polyps. Scand. J. Gastroenterol., 22 (1987) 13–16.

    Article  PubMed  CAS  Google Scholar 

  132. Kikendall J, Bowen P, Burgess M, etal. Cigarettes and alcohol as independent risk factors for colonic adenomas. Gastroenterology, 97 (1989) 660–664.

    PubMed  CAS  Google Scholar 

  133. Zahm S, Cocco P, and Blair A. Tobacco smoking as a risk factor for colon polyps. Am. J. Public Health, 81 (1991) 846–849.

    Article  PubMed  CAS  Google Scholar 

  134. Monnet E, Allemand H, Farina H, etal. Cigarette smoking and the risk of colorectal adenoma in men. Scand. J. Gastroenterol., 26 (1991) 758–762.

    Article  PubMed  CAS  Google Scholar 

  135. Kune G, Kune S, Watson L, etal. Smoking and colorectal adenomatous polyps [letter]. Gastroenterology, 103 (1992) 1370–1371.

    PubMed  CAS  Google Scholar 

  136. Honjo S, Kono S, Shinchi K, etal. Cigarette smoking, alcohol use and adenomatous polyps of the sigmoid colon. Jpn. J. Cancer Res., 83 (1992) 806–811.

    Article  PubMed  CAS  Google Scholar 

  137. Giovannucci E and Martinez M. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J. Natl. Cancer Inst., 88 (1996) 1717–1730.

    Article  PubMed  CAS  Google Scholar 

  138. Terry MB and Neugut AI. Cigarette smoking and the colorectal-adenoma sequence: a hypothesis to explain the paradox. Am. J. Epidemiol.,147 (1998) 903–910.

    Google Scholar 

  139. Terry MB, Neugut AI, Schwartz S, etal. Risk factors for a causal intermediate and an endpoint: reconciling differences. Am. J. Epidemiol., 151 (2000) 339–345.

    Article  PubMed  CAS  Google Scholar 

  140. Boutron M, Faivre J, Dop M, etal. Tobacco, alcohol, and colorectal tumors: a multistep process. Am. J. Epidemiol.,141 (1995) 1038–1046.

    Google Scholar 

  141. Heineman E, Zahm S, McLaughlin J, etal. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int. J. Cancer, 59 (1995) 728–738.

    Article  Google Scholar 

  142. Slattery M, West D, Robison L, etal. Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population. Epidemiology, 1 (1990) 141–145.

    Google Scholar 

  143. Martinez I, Torres R, Frias Z, etal. Factors associated with adenocarcinomas of the large bowel in Puerto Rico. In Advances in Medical Oncology, Research, and Education. Pergamon, Oxford, 1978, pp. 45–52.

    Google Scholar 

  144. Vobecky J, Caro J, and Devroede G. A case-control study of risk factors for large-bowel carcinoma. Cancer, 51 (1983) 1958–1963.

    Article  PubMed  CAS  Google Scholar 

  145. Jarebinski M, Adanja B, and Vlajinac H. Case-control study of relationship of some biosocial correlates to rectal cancer patients in Belgrade, Yugoslavia. Neoplasma, 36 (1989) 369–374.

    Google Scholar 

  146. Kune G, Kune S, Vitetta L, etal. Smoking and colorectal cancer risk: data from the Melbourne Colorectal Cancer Study and brief review of the literature. Int. J. Cancer, 50 (1992) 369–372.

    Article  PubMed  CAS  Google Scholar 

  147. Williams R and Horm J. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J. Natl. Cancer Inst., 58 (1977) 525–547.

    PubMed  CAS  Google Scholar 

  148. Haenszel W, Locke F, and Segi M. A case-control study of large-bowel cancer in Japan. J. Natl. Cancer Inst., 64 (1980) 17–22.

    PubMed  CAS  Google Scholar 

  149. Ferraroni M, Negri E, La Vecchia C, etal. Socioeconomic indicators, tobacco, and alcohol in the aetiology of digestive tract neoplasms. Int. J. Epidemiol., 18 (1989) 556–562.

    Article  PubMed  CAS  Google Scholar 

  150. Choi S and Kahyo H. Effect of cigarette smoking and alcohol consumption in the etiology of cancer of the digestive tract. Int. J. Cancer, 49 (1991) 382–386.

    Article  Google Scholar 

  151. Chute C, Willett W, Colditz G, etal. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control, 2 (1991) 117–124.

    Article  PubMed  CAS  Google Scholar 

  152. Tverdal A, Thelle D, Stensvold I, etal. Mortality in relation to smoking history: 13 years’ follow-up of 68,000 Norwegian men and women 35–49 years. J. Clin. Epidemiol., 46 (1993) 475–487.

    Article  PubMed  CAS  Google Scholar 

  153. Daniell H. More advanced colonic cancer among smokers. Cancer, 58 (1986) 784–787.

    Article  PubMed  CAS  Google Scholar 

  154. Longnecker M, Clapp R, and Sheahan K. Associations between smoking status and stage of colorectal cancer at diagnosis in Massachusetts between 1982 and 1987. Cancer, 64 (1989) 1372–1374.

    Article  PubMed  CAS  Google Scholar 

  155. Anton-Culver H. Smoking and other risk factors associated with the stage and age of diagnosis of colon and rectum cancers. Cancer Detect. Prey.,15 (1991) 345–350.

    Google Scholar 

  156. Robinette C, Hrubec Z, and Fraumeni JF Jr. Chronic alcoholism and subsequent mortality in World War II veterans. Am. J. Epidemiol., 109 (1979) 687–700.

    PubMed  Google Scholar 

  157. Schmidt W and Popham R. The role of drinking and smoking in mortality from cancer and other causes in male alcoholics. Cancer,47 (1981) 1031–1041.

    Google Scholar 

  158. Dean G, MacLennan R, McLoughlin H, etal. Causes of death of blue-collar workers at a Dublin brewery. Br. J. Cancer, 40 (1979) 581–590.

    Article  PubMed  CAS  Google Scholar 

  159. Giovannucci E, Rimm E, Ascherio A, etal. Alcohol, low-methionine-low-folate diets and the risk of colon cancer in men. J. Natl. Cancer Inst., 87 (1995) 265–273.

    Article  PubMed  CAS  Google Scholar 

  160. Gordon T and Kannel W. Drinking and mortality: the Framingham study. Am. J. Epidemiol., 120 (1984) 97–107.

    PubMed  CAS  Google Scholar 

  161. Klatsky A, Armstrong M, Friedman G, etal. The relations of alcoholic beverage use to colon and rectal cancer. Am. J. Epidemiol., 128 (1988) 1007–1015.

    PubMed  CAS  Google Scholar 

  162. Hirayama T. Association between alcohol consumption and cancer of the sigmoid colon: observations from a Japanese cohort study. Lancet, 334 (1989) 725–727.

    Article  Google Scholar 

  163. Stemmermann G, Nomura A, Chyou P, etal. Prospective study of alcohol intake and large bowel cancer. Dig. Dis. Sci., 35 (1990) 1414–1420.

    Article  PubMed  CAS  Google Scholar 

  164. Peters R, Pike M, Garabrant D, etal. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control, 3 (1992) 457–473.

    Article  PubMed  CAS  Google Scholar 

  165. Potter J and McMichael A. Diet and cancer of the colon and rectum: a case-control study. J. Natl. Cancer Inst., 76 (1986) 557–569.

    PubMed  CAS  Google Scholar 

  166. Tuyns A, Kaaks R, and Haelterman M. Colorectal cancer and the consumption of foods: a case-control study in Belgium. Nutr. Cancer, 11 (1988) 189–204.

    Article  PubMed  CAS  Google Scholar 

  167. Miller A, Howe G, Jain M, etal. Food items and food groups as risk factors in a case-control study of diet and colorectal cancer. Int. J. Cancer, 32 (1983) 155–161.

    Article  PubMed  CAS  Google Scholar 

  168. Tuyns A, Pequignot G, Gignoux M, etal. Cancers of the digestive tract, alcohol and tobacco. Int. J. Cancer, 30 (1982) 9–11.

    Article  PubMed  CAS  Google Scholar 

  169. Kune S, Kune G, and Watson L. Case-control study of alcoholic beverages as etiologic factors: the Melbourne Colorectal Cancer Study Group. Nutr. Cancer, 9 (1987) 43–56.

    Article  PubMed  CAS  Google Scholar 

  170. Freudenheim J, Graham S, Marshall J, etal. A case-control study of diet and rectal cancer in western New York. Am. J. Epidemiol., 131 (1990) 612–624.

    PubMed  CAS  Google Scholar 

  171. Potter J. Nutrition and colorectal cancer. Cancer Causes Control, 7 (1995) 127–146.

    Article  Google Scholar 

  172. Kohl H, LaPorte R, and Blaire S. Physical activity and cancer. An epidemiological perspective. Sports Med., 6 (1988) 222–237.

    Article  PubMed  CAS  Google Scholar 

  173. Lee I-M, Paffenbarger RJ, and Hsieh C. Physical activity and risk of developing colorectal cancer among college alumni. J. Natl. Cancer Inst., 83 (1991) 1324–1329.

    Article  PubMed  CAS  Google Scholar 

  174. Mann G. The influence of obesity on health. N. Engl. J. Med., 291 (1974) 178–232.

    Article  PubMed  CAS  Google Scholar 

  175. Simonopoulos A and Van Itallie T. Body weight, health and longevity. Ann. Intern. Med., 100 (1984) 285–295.

    Article  Google Scholar 

  176. Neugut AI, Lee WC, Garbowski GC, etal. Obesity and colorectal adenomatous polyps. J. Natl. Cancer Inst., 83 (1991) 359–361.

    Article  PubMed  CAS  Google Scholar 

  177. Bayerdorffer E, Mannes G, Ochsenkuhn T, etal. Increased risk of “high-risk” colorectal adenomas in overweight men. Gastroenterology, 104 (1993) 137–144.

    PubMed  CAS  Google Scholar 

  178. Lee E and Garfinkel L. Variations in mortality by weight among 750,000 men and women. J. Chronic Dis., 32 (1979) 563–576.

    Article  Google Scholar 

  179. Williams S, Sorlie P, Feinlieb M, etal. Cancer incidence by levels of cholesterol. JAMA, 245 (1981) 247–252.

    Article  PubMed  CAS  Google Scholar 

  180. Must A, Jacques P, Dallard G, etal. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N. Engl. J. Med., 327 (1992) 1350–1355.

    Article  PubMed  CAS  Google Scholar 

  181. Lee I-M and Paffenbarger RJ. Quetelet’s index and risk of colon cancer in college alumni. J. Natl. Cancer Inst., 84 (1992) 1326–1331.

    Article  PubMed  CAS  Google Scholar 

  182. Le Marchand L, Wilkens L, and Ming-Pi M. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control, 3 (1992) 349–354.

    Article  PubMed  Google Scholar 

  183. Slattery M, Abd-Elghany N, Kerber R, etal. Physical activity and colon cancer: a comparison of various indicators of physical activity to evaluate the association. Epidemiology, 1 (1990) 481–485.

    Article  PubMed  CAS  Google Scholar 

  184. Gerhardsson de Verdier M, Broderus B, and Norell S. Physical activity and colon cancer risk. Int. J. Epidemiol., 17 (1988) 743–746.

    Article  Google Scholar 

  185. Slattery M, Schumacher M, Smith K, etal. Physical activity, diet and risk of colon cancer in Utah. Am. J. Epidemiol., 128 (1988) 989–999.

    PubMed  CAS  Google Scholar 

  186. Gerhardsson de Verdier M, Hagman U, Steineck G, etal. Diet, body mass and colorectal cancer: a case-referent study. Int. J. Cancer, 46 (1990) 832–838.

    Article  Google Scholar 

  187. MacLennan S, MacLennan A, and Ryan P. Colorectal cancer and oestrogen replacement therapy: a meta-analysis of epidemiological studies. Med. J. Aust., 162 (1995) 491–493.

    PubMed  CAS  Google Scholar 

  188. Kampman E, Potter J, Slattery M, etal. Hormone replacement therapy, reproductive history, and colon cancer: a multi-center case-control study in the United States. Cancer Causes Control, 8 (1997) 146–158.

    Article  PubMed  CAS  Google Scholar 

  189. Troisi R, Schairer C, Chow W-H, etal. A prospective study of menopausal hormones and risk of colorectal cancer in the United States. Cancer Causes Control, 8 (1997) 130–138.

    Article  PubMed  CAS  Google Scholar 

  190. Crandall C. Estrogen replacement and colon cancer: a clinical review. J. Women’s Health Gender-Based Med., 8 (1999) 1155–1166.

    Article  CAS  Google Scholar 

  191. Jacobson JS, Neugut AI, Garbowski GC, etal. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control, 6 (1995) 513–518.

    Article  PubMed  CAS  Google Scholar 

  192. Neugut AI and Forde KA. Screening colonoscopy: has the time come? Am. J. Gastroenterol., 83 (1988) 295–297.

    PubMed  CAS  Google Scholar 

  193. Lieberman D, Weiss D, Bond J, etal. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veteran’s Affairs Cooperative Study Group 380. N. Engl. J. Med., 343 (2000) 162–168.

    Article  PubMed  CAS  Google Scholar 

  194. Schatzkin A, Lanza E, Corle D, etal. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N. Engl. J. Med., 342 (2000) 1149–1155.

    Article  PubMed  CAS  Google Scholar 

  195. Alberts D, Martinez M, Roe D, etal. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N. Engl. J. Med., 342 (2000) 1156–1162.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Talbot, S.M., Neugut, A.I. (2002). Epidemiological Trends in Colorectal Cancer. In: Saltz, L.B. (eds) Colorectal Cancer. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-160-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-160-2_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9670-3

  • Online ISBN: 978-1-59259-160-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics